Literature DB >> 24941322

MicroRNAs and ceRNAs: therapeutic implications of RNA networks.

Dana Elena Giza1, Catalin Vasilescu, George A Calin.   

Abstract

INTRODUCTION: A new concept of gene regulation, in which competitive endogenous RNAs (ceRNAs) compete for common microRNAs (miRNAs), suggests that mRNA targets have an active role as key elements in the regulation of miRNA availability within cells. ceRNAs are considered to be natural decoys of miRNA activity and can influence the expression of multiple miRNAs. AREAS COVERED: A new complex network of indirect interaction among the RNA transcripts competing for the same pool of miRNAs has been described; in this network, the nodes are the targets, and the links between the nodes are the miRNAs the targets have in common, which form smaller subnetworks. The incidence, state and severity of cancer can be evaluated on the basis of this network signature. The study of these new genome-scale regulatory networks involving miRNAs and ceRNAs may provide information that researchers can use to fine-tune these networks to improve responses to cancer therapy and/or develop new therapeutic interventions. EXPERT OPINION: Combinational approaches based on complex regulatory ceRNA networks (ceRNETs) may be one of the most promising strategies for silencing important mediators of cancer-promoting pathways. Targeting a single miRNA may in fact represent a combined intervention that acts on the feedback and compensatory pathways that can impair treatment response or cause treatment resistance.

Entities:  

Keywords:  competitive endogenous RNA; competitive endogenous RNA networks; decoy activity; gene regulatory networks; microRNA; network-based therapy

Mesh:

Substances:

Year:  2014        PMID: 24941322     DOI: 10.1517/14712598.2014.920812

Source DB:  PubMed          Journal:  Expert Opin Biol Ther        ISSN: 1471-2598            Impact factor:   4.388


  28 in total

Review 1.  Levels of MicroRNA Heterogeneity in Cancer Biology.

Authors:  Nina Petrovic; Sercan Ergün; Esma R Isenovic
Journal:  Mol Diagn Ther       Date:  2017-10       Impact factor: 4.074

2.  Identifying survival-associated modules from the dysregulated triplet network in glioblastoma multiforme.

Authors:  Jia-Bin Wang; Feng-Hua Liu; Jian-Hang Chen; Hai-Tao Ge; Lu-Yan Mu; Hong-Bo Bao; Zhi-Guo Lin
Journal:  J Cancer Res Clin Oncol       Date:  2017-02-06       Impact factor: 4.553

Review 3.  Oncocers: ceRNA-mediated cross-talk by sponging miRNAs in oncogenic pathways.

Authors:  Sercan Ergun; Serdar Oztuzcu
Journal:  Tumour Biol       Date:  2015-03-27

4.  The lncRNA MIAT/miR-181a-5p axis regulates osteopontin (OPN)-mediated proliferation and apoptosis of human chondrocytes in osteoarthritis.

Authors:  Suolin Zeng; Min Tu
Journal:  J Mol Histol       Date:  2022-03-14       Impact factor: 2.611

Review 5.  MicroRNA-mediated interactions between host and hepatitis C virus.

Authors:  Hu Li; Jian-Dong Jiang; Zong-Gen Peng
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

Review 6.  Urothelial cancer associated 1: a long noncoding RNA with a crucial role in cancer.

Authors:  Mei Xue; Wei Chen; Xu Li
Journal:  J Cancer Res Clin Oncol       Date:  2015-09-04       Impact factor: 4.553

7.  A Comprehensive RNA Study to Identify circRNA and miRNA Biomarkers for Docetaxel Resistance in Breast Cancer.

Authors:  Peide Huang; Fengyu Li; Zongchao Mo; Chunyu Geng; Fang Wen; Chunyan Zhang; Jia Guo; Song Wu; Lin Li; Nils Brünner; Jan Stenvang
Journal:  Front Oncol       Date:  2021-05-14       Impact factor: 6.244

8.  Key principles of miRNA involvement in human diseases.

Authors:  Dana Elena Giza; Catalin Vasilescu; George A Calin
Journal:  Discoveries (Craiova)       Date:  2014 Oct-Dec

Review 9.  Competing endogenous RNA networks: tying the essential knots for cancer biology and therapeutics.

Authors:  Avencia Sanchez-Mejias; Yvonne Tay
Journal:  J Hematol Oncol       Date:  2015-03-28       Impact factor: 17.388

10.  Long noncoding RNA FER1L4 suppresses cancer cell growth by acting as a competing endogenous RNA and regulating PTEN expression.

Authors:  Tian Xia; Shengcan Chen; Zhen Jiang; Yongfu Shao; Xiaoming Jiang; Peifei Li; Bingxiu Xiao; Junming Guo
Journal:  Sci Rep       Date:  2015-08-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.